Epharmacy startup PhramEasy made a surprising announcement on Friday that it is acquiring a controlling stake in Thyrocare Diagnostic Technologies Ltd for INR 4,546 Cr. The controlling stake amounts to nearly 66.1% stake at per share valuation of Rs 1,300.
It is probably for the first time that an emerging startup, which is barely few years…
